Exercise-induced myocardial ischemia in isolated coronary artery ectasias and aneurysms (“dilated coronaropathy”)  by Krüger, Dietmar et al.
Coronary Ectasia
Exercise-Induced Myocardial Ischemia
in Isolated Coronary Artery Ectasias
and Aneurysms (“Dilated Coronaropathy”)
Dietmar Kru¨ger, MD,* Ulrich Stierle, MD,† Gunhild Herrmann, MD,*
Ru¨diger Simon, MD, FACC, FESC,* Abdolhamid Sheikhzadeh, MD, FACC, FESC†
Lu¨beck and Kiel, Germany
OBJECTIVES The purpose of our study was to evaluate the clinical significance of isolated coronary artery
ectasias or aneurysms (CEA).
BACKGROUND It has been postulated that altered coronary blood flow in CEA predisposes patients to the
development of myocardial ischemia (CI) and infarction.
METHODS Sixty-seven patients with bilateral nonobstructive CEA without associated cardiac defects
(“dilated coronaropathy”) were derived from 16,341 cardiac catheterizations between 1986
and 1997. Ectasias were defined as luminal dilation of 1.5- to 2.0-fold, aneurysms of
.2.0-fold of normal limits. Eleven of 25 patients presented with myocardial infarction due
to an occlusion of the infarct vessel. In 42 patients without infarction (study group),
exercise-induced CI was investigated.
RESULTS A corresponding CI was documented in 32 of 42 patients in a coronary sinus lactate study
(reduced lactate extraction 5.6 6 4.1%) and in 29 of 40 patients in an ergometry (0.25 6
0.06 mV ST depressions). The results differed significantly from a control group of 29
patients without heart disease (p , 0.001). Nitroglycerin (0.8 mg) provoked a further
significant deterioration of CI in the 32 of 42 developing a frank cardiac lactate production
(22.6 6 6.8%, p , 0.001). The metabolic extent of CI was significantly correlated to the
coronary diameters of the proximal and middle segments of left anterior descending artery
and the middle segment of left circumflex artery (r 5 0.87, p , 0.001). Stigmata of an
impaired coronary blood flow such as delayed antegrade filling, segmental backflow
phenomenon and local deposition of dye were found significantly more often with increasing
coronary diameters (p , 0.04).
CONCLUSIONS “Dilated coronaropathy” is an entity of nonobstructive, ischemic coronary artery disease.
Nitroglycerin is of no therapeutic benefit but leads to an aggravation of exercise-induced CI.
(J Am Coll Cardiol 1999;34:1461–70) © 1999 by the American College of Cardiology
Coronary artery ectasias or aneurysms (CEA) are a rare
finding among coronary artery anomalies and are considered
to be of congenital origin or acquired (1–3). The entity
comprises different morphological manifestations of a lumi-
nal dilation of the coronary arteries. The angiographic
incidence in diagnostic cardiac catheterizations has been
found to vary between 0.3% and 4.9% (4–7).
Due to a lack of a uniform definition, the terms “ectasia”
and “aneurysm” have been used inaccurately and regardless
of coincident coronary artery stenosis.
Coronary artery ectasias or aneurysms are attributed to
atherosclerosis in 50%, whereas 20% to 30% have been
considered congenital in origin. Only 10% to 20% of CEA
have been described in association with inflammatory or
connective tissue diseases (2,8).
Independent of the etiology, the clinical symptomatology
consists of a typical exercise-induced angina pectoris. As a
complication, myocardial infarction may occur, caused by
repeated dissemination of microemboli to segments distal to
the ectasia or aneurysm or by a thrombotic occlusion of the
dilated vessel (9–11). For this reason, clinical aspects do not
allow to distinguish between CEA and atherosclerotic
occlusive coronary artery disease.
Based on case reports and small series, some authors have
postulated that CEA may induce myocardial ischemia (CI)
without coincident significant coronary artery stenosis or
other cardiac defects, respectively (4,5,8).
Angiographic signs of an impaired coronary blood flow in
these isolated CEA are a delayed antegrade coronary dye
filling, a segmental back flow phenomenon and a local
deposition of dye in the dilated coronary segment (5,12).
In our study, a systematic evaluation of a potential
exercise-induced CI in patients with bilateral isolated CEA
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(“dilated coronaropathy”) was performed. Another aim of
the present study was to elucidate the extent to which
coronary luminal enlargement and pathological coronary
flow patterns correlate with the intensity of CI and whether
nitroglycerin (NTG) would be of therapeutic benefit.
METHODS
Evaluation of coronary angiography. Coronary angiogra-
phy was routinely performed without the use of NTG. The
coronary artery tree was subdivided into a proximal, middle
and distal segment. The proximal segment of the left
anterior descending coronary artery (LAD) was defined as
the vessel part between the left main trunk (LMT) and the
first diagonal branch, proximal segment of LAD (LADp),
the middle segment between the first and second diagonal
branch, median segment of LAD (LADm) and the segment
distal to the second diagonal branch, distal segment of LAD
(LADd). The corresponding segments in the left circumflex
artery (LCX) were designated by the emanating first and
second obtuse marginal branch, in the right coronary artery
(RCA) by the emanating acute marginal branch and by the
bifurcation into the posterior descending artery and poste-
rior left ventricular branch. Coronary diameters were mea-
sured as the maximum diameter of each segment by means
of computerized quantitative angiography in a biplane mode
(DCI; Philips, Eindhoven, Netherlands). For calibration,
the tip of the coronary catheter was used.
According to the angiographic definition of Falsetti and
Carroll (2) and Befeler et al. (8), CEAs were defined as
nonobstructive lesions of the epicardial coronary arteries
with a luminal dilation exceeding the 1.5- to 2.0-fold of
normal diameters, and a coronary aneurysm was defined as
a dilation .2.0-fold of normal diameters. If no adjacent
normal segment could be identified, the mean diameters of
the coronary segments in a control group without heart
disease (n 5 29) served as normal values. A significant
stenosis in an ectatic or aneurysmatic segment was defined
as a $50% loss of the diameter in an adjacent normal
segment or the corresponding diameter measured in the
control group. A saccular CEA is that in which the
transverse diameter is greater than the longitudinal exten-
sion, whereas a fusiform ectasia or aneurysm is a dilation
along the axis of the vessel with reverse proportions (8). Our
study group consisted of patients with a bilateral fusiform
manifestation of “dilated coronaropathy,” involving both the
right and left coronary artery. Patients with CEA in
addition to significant stenosis or occlusion of the coronary
arteries, as well as patients with prior myocardial infarction,
were excluded from the study.
Coronary angiographies were screened for the following
angiographic signs of an impaired coronary blood flow (Fig.
1A and B): 1) delayed antegrade coronary dye filling and
drainage (slow flow); 2) segmental back flow phenomenon
(milking phenomenon); and 3) local deposition of dye in the
dilated coronary segments (stasis).
Abbreviations and Acronyms
beats/min 5 beats per minute
CEA 5 coronary artery ectasias or aneurysms
CI 5 myocardial ischemia
CLM 5 cardiac lactate metabolism
CS 5 coronary sinus
ECG 5 electrocardiogram
LAD 5 left anterior descending coronary artery
LADd 5 distal segment of LAD
LADm 5 median segment of LAD
LADp 5 proximal segment of LAD
LCX 5 left circumflex artery
LMT 5 left main trunk
MET 5 mean metabolic equivalent
NTG 5 nitroglycerin
RCA 5 right coronary artery
Figure 1. Coronary angiography of the left coronary artery of a
52-year-old man (7 F Judkins coronary catheter, 30° right anterior
oblique projection). (A) Large fusiform aneurysms affecting the
proximal and middle segment of the LAD and LCX are depicted.
(B) After five cardiac cycles, a delayed antegrade filling and
drainage in the LCX (“slow flow”) and a local deposition of dye
(“stasis”) in the middle segment of the LAD are documented.
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Evidence of exercise-induced CI. Stress testing was per-
formed by means of ergometry and coronary sinus lactate
study with incremental atrial pacing to evaluate a potential
exercise-induced CI.
ERGOMETRY. Exercise stress testing was performed by
means of a standard Bruce treadmill protocol or by a bicycle
ergometry. The appearance of angina pectoris and signifi-
cant ST segment changes were documented according to
the criteria of the American Heart Association (13,14).
CORONARY SINUS LACTATE STUDY. The investigation was
performed two days after diagnostic coronary angiography.
No drugs were given 48 h before the study. Patients with
preexisting ST segment abnormalities (due, for example, to
left or right bundle branch block, left ventricular hypertro-
phy or digitalis medication) were excluded from the study.
All patients presented with a stable sinus rhythm. At the
beginning, all patients were free of symptoms and had no
evidence of CI on a 12-lead electrocardiogram (ECG). A 7
F Zucker catheter (USCI, Bard, Ireland) was positioned
with its tip 2 to 5 cm from the orifice of the coronary sinus
to minimize the risk of admixture of right atrial blood in the
samples (15). The correct position was confirmed by hand
injection of dye and by an oxygen saturation measurement.
Pacing was performed for 3 min each at 100, 120 and 140
beats per minute (beats/min) and three times at 160
beats/min. A 12-lead ECG was obtained before pacing,
after each 3-min pacing period and for 5 min at 1-min
intervals after cessation of pacing. Paired samples for lactate
were withdrawn from the coronary sinus (cs) and an
indwelling catheter in the radial or femoral artery (a) before
pacing (baseline), at the end of every 3-min pacing interval
and at 1, 3 and 5 min after cessation of pacing. Myocardial
metabolism is normally aerobic, but in the presence of CI,
anaerobic metabolism develops. This results in a decrease in
lactate extraction by the myocardium, with a resulting
increase in the lactate content of the coronary sinus. Per
definition, positive values of the cardiac lactate metabolism
(CLM) stand for a lactate extraction, and negative values
stand for lactate production. A moderate CI was defined as
a reduction of cardiac lactate extraction ,10%, a severe CI
as a frank cardiac lactate production ,0% (16–19):
~@a# 2 @cs# 3 @a#21! 3 100 5 CLM (%)
Pacing was stopped when typical angina pectoris oc-
curred. The duration of CI was quantified by the persistence
of angina and ST segment depressions in the 12-lead ECG,
as well as pathological CLM after cessation of pacing. After
a recovery time of 45 min, the study was repeated after
sublingual administration of 0.8 mg NTG. According to the
extent of CI, subgroups should be characterized to evaluate
the clinical significance of coronary artery ectasias versus
aneurysms.
All patients in the study and control groups gave written
informed consent, and the study was approved by the
hospital ethics committee.
Statistical analysis. The differences in values between the
CLM before pacing and at every sampling time were
assessed by an alpha-adjusted Bonferroni analysis (multiple
comparison analysis) preceded by a two-way analysis of
variance with repeated measures (p , 0.005 was considered
significant). A comparison of the extent of angiographic
signs of an impaired blood flow between subgroups of the
study group was calculated by means of Fisher exact test. A
Spearman correlation analysis was performed to investigate
the influence of the coronary diameters in CEA on the
severity of the ischemic response to pacing stress assessed by
CLM in the coronary sinus study. After testing for normal
distribution, the data of coronary artery diameters in the
study and control group were compared by an unpaired
Student t test. Values are presented as mean value 6 SD
(p , 0.05 was considered significant).
RESULTS
Patient characteristics. Sixty-seven patients with bilateral
fusiform isolated CEA were selected from 16,341 consecu-
tive cardiac catheterizations at the University Hospitals
Lu¨beck (January 1986 to June 1994) and Kiel (July 1994 to
June 1997). The overall incidence of ectasias and aneurysms
in our population was 507 out of 16,341 (3.1%). Fourteen
patients with a saccular manifestation, 39 patients with a
unilateral fusiform manifestation and 387 patients with
ectasias and aneurysms associated with significant coronary
artery stenosis were excluded from the study.
In patients with “dilated coronaropathy,” age, gender
(53.2 6 7.3 years, 53 men, 14 women) and the risk profile
for atherosclerotic cardiovascular disorders (arterial hyper-
tension, diabetes mellitus, hyperlipidemia, nicotine abuse)
did not differ significantly from the control group (50.9 6
5.8 years, 24 men, 5 women).
Twenty-five of 67 patients had been admitted to the
hospital because of a myocardial infarction (7 non-Q wave,
18 Q wave infarctions). In 11 of 25 cases, an occlusion of the
infarct vessel was found beside the CEA; in 14 of 25
patients, coronary angiography revealed an open infarct
vessel. Our study group consisted of the 42 patients with
“dilated coronaropathy” without prior myocardial infarction.
Thirty-seven of 42 patients in the study group presented
with typical exertional angina pectoris; 16 of them had class
II angina, and 11 had class III angina according to the
definitions of the Canadian Cardiovascular Society. Ten of
37 patients with typical angina even suffered from recurrent
resting chest pain. The other 5 of 42 patients complained of
atypical angina pectoris. The symptoms in all patients in our
study group were frequent and severe enough to warrant
referral for evaluation of suspected CI.
Diagnostic of exercise-induced CI. ERGOMETRY. The ex-
ercise stress test was performed in 31 patients by means of
a Bruce treadmill ergometry and in 9 patients by a bicycle
ergometry. In two patients, ergometry could not be done,
because of obstructive pulmonary disease. Exercise provoked
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angina pectoris in 32 of 40 patients; in 29 of 40 patients
significant ST segment depressions developed with a max-
imum of 0.25 6 0.06 mV at a mean metabolic equivalent
(MET) of 5.9 6 1.7 and an attained heart rate of 81.0% 6
16.6% of the age-predicted maximum heart rate. Angina
pectoris and ST segment depressions persisted for 3.2 6
0.7 min into the recovery time.
In the control group, only 2 of 29 patients, who did not
develop angina pectoris, met electrocardiographic criteria of
CI. Three of 29 patients complained of exercise-induced
chest pain without significant ST segment changes. The heart
rate attained at the end of the test was 102.7% 6 11.4% of the
age-predicted maximum heart rate at 9.7 6 2.4 MET.
CORONARY SINUS LACTATE STUDY WITH INCREMENTAL
ATRIAL PACING. Forty-two patients underwent incremental
coronary sinus pacing. Cardiac lactate metabolism gradually
changed from a physiological lactate extraction of 28.5% 6
9.9% to 5.6% 6 4.1%, indicating CI, as depicted in Figure
2A. Significant differences in mean cardiac lactate levels
Figure 2. Coronary sinus lactate study with incremental atrial pacing in CEA. The rates of CLM (mean 6 SD) without premedication
(open bars) and after the administration of 0.8 mg NTG (solid bars) are depicted on the ordinate. The time of blood sampling appears
on the abscissa: baseline (BL) and every 3 min during incremental atrial pacing at 100, 120, 140 and three times 160 beats/min, 1, 3 and
5 min after cessation of pacing. Within the bars, the number of patients is indicated in whom pacing had to be stopped prematurely because
of angina pectoris. (A) All patients of the study group (n 5 42). (B) Patients with frank cardiac lactate production (subgroup I, n 5 18).
(C) Patients with moderate myocardial ischemia (subgroup II, n 5 14). (D) Patients without metabolic evidence of cardiac ischemia
(subgroup III, n 5 10).
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were found between the baseline data and the data recorded
at each 3-min pacing period at 160 beats/min (p , 0.001).
Pacing induced angina pectoris in 34 of 42; in 16 patients
pacing was stopped before the end of the protocol because
of angina pectoris. In 31 of 42 patients, significant ST
segment depressions of 0.31 6 0.09 mV were documented
after cessation of pacing; the attained heart rate was 91.5%
6 11.4% of the age-predicted maximum heart rate. Angina
pectoris and ST segment depressions persisted for 2.7 6
0.5 min, whereas an instantaneous consolidation of CLM
was documented 1 min after cessation of pacing.
After NTG administration, the pacing protocol had to be
terminated prematurely in 23 patients because of an even
earlier appearance of angina pectoris. Pathological ST seg-
ment depressions were noted in all 31 patients again (0.30 6
0.11 mV), although pacing had attained a heart rate of only
72.9% 6 13.9% of the age-predicted maximum heart rate.
Angina pectoris and ST segment depressions persisted for
3.9 6 0.9 min into the recovery time. Nitroglycerin exerted
a further marked alteration of the CLM, with an overall
frank cardiac lactate production of 22.6% 6 6.8% in the
study group. A subsequent abnormal reduction of cardiac
lactate extraction was found 1 and 3 min after cessation of
pacing. Significant differences in mean cardiac lactate levels
were found between the baseline data and the data recorded
at 140 beats/min, 160 beats/min, 1 min, 3 min and 5 min
after pacing, respectively (p , 0.001).
Further significant differences were found between the
Figure 2. Continued.
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mean cardiac lactate levels with NTG versus without NTG
at each 3-min pacing period at 160 beats/min and at 1 min,
3 min and 5 min after pacing (p , 0.003).
Metabolic evidence of myocardial ischemia was found in
32 of 42 patients in the study group. Based upon the severity
of CI measured by means of CLM, the study group was
divided into three subgroups. Subgroup I (n 5 18) was
defined by a pacing-induced frank cardiac lactate production
in all patients after administration of NTG. In this sub-
group, NTG exerted its most paradoxical effect with a
marked aggravation of myocardial ischemia persisting for
the whole recovery period. In 11 patients, pacing had
induced a lactate production without NTG premedication
(Figure 2B). Subgroup II (n 5 14) was characterized by a
pathologically reduced cardiac lactate extraction ,10% be-
fore and after NTG (Fig. 2C). Subgroup III (n 5 10)
represented individuals with only slightly altered cardiac
lactate extraction rates (Fig. 2D).
Improvement of symptoms, reduction of ischemia-
induced ST segment depressions or an improvement of
CLM by NTG could not be documented in any patient.
Nitroglycerin provoked a significant, marked alteration of
the CLM (p , 0.003) and even a change into a lactate
production in the overall study population (Fig. 2A),
predominantly based on its effect found in subgroup I
(Fig. 2B).
In the control group, pacing provoked chest discomfort in
2 of 29 patients; CI was proved to be the result of neither
electrocardiographic nor metabolic criteria. Pacing was re-
peated in 10 of 29 patients after NTG in the control group;
the results remained unchanged.
Consistent with the results of the coronary sinus study, a
severe CI was also provoked by ergometry in 17 of 18
patients of subgroup I. In 10 of 14 patients with patholog-
ically reduced lactate extraction (subgroup II), ergometry
revealed CI as well. In subgroup III, with no metabolic
evidence of CI, only 2 of 10 patients demonstrated a
pathological ergometry.
Table 1. Coronary Artery Diameters in the Control Group and in Patients with CEA
All
Segments
Control Group CEA Subgroup I Subgroup II Subgroup III
*
LMT 4.24 6 0.87 8.69 6 1.53 9.45 6 1.63 8.28 6 1.54 7.91 6 1.76
LADp 3.56 6 0.66 7.70 6 1.55 9.06 6 1.28 6.74 6 0.87 6.44 6 0.71
†
LADm 2.76 6 0.92 6.82 6 1.76 8.29 6 1.89 5.74 6 1.52 5.68 6 0.90
†
LADd 1.64 6 0.59 3.59 6 1.46 4.54 6 1.50 3.18 6 1.26 2.44 6 0.72
†
LCXp 3.26 6 0.62 6.31 6 1.41 7.32 6 0.96 5.65 6 1.29 5.41 6 1.38
†
LCXm 2.47 6 0.79 5.84 6 1.44 6.31 6 1.42 5.45 6 1.66 5.54 6 1.11
LCXd 1.45 6 0.53 3.01 6 0.96 3.71 6 1.11 2.44 6 0.76 2.53 6 0.56
†
RCAp 3.57 6 0.81 7.34 6 1.65 8.29 6 1.49 7.33 6 1.47 5.65 6 1.31
†
RCAm 2.73 6 0.71 6.64 6 1.65 7.16 6 2.32 6.51 6 1.04 5.89 6 1.80
RCAd 1.54 6 0.46 3.49 6 1.21 4.22 6 0.80 2.93 6 0.96 2.96 6 1.48
†
Values shown are the mean 6 SD coronary diameters of the left main trunk (LMT), proximal (p), middle (m) and distal (d)
segments of the left anterior descending (LAD), left ramus circumflexus (LCX) and right coronary artery (RCA) in the control
group and all patients with coronary artery ectasias or aneurysms (CEA) as well as the subgroups I to III. Significant differences
are indicated (*p , 0.02, †p , 0.04).
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Coronary artery diameters. The coronary artery diameters
in “dilated coronaropathy” and its respective subgroups were
compared with the diameters in the control group (Table 1).
In most segments, significant differences were found not
only in comparison with the control group (p , 0.02), but
also among the three subgroups (p , 0.04). The coronary
diameters of the control group were in accordance with data
reported in literature (20).
To evaluate the influence of coronary diameter enlarge-
ment in CEA on the severity of exercise-induced CI, a
correlation analysis between the study group diameters in
the proximal LAD and the CLM was performed. A
Spearman analysis (Fig. 3) revealed a significant correlation
(r 5 0.87, p , 0.001), indicating that the extent of CI
strongly depended on the size of luminal enlargement in
CEA. A significant correlation was also found between the
extent of CI and the diameters in the middle segments of
the LAD and LCX, respectively.
Angiographic patterns. The angiographic findings of the
subgroups are presented in Table 2. The coronary lesions in
subgroup I can be described as coronary artery aneurysms
with the largest coronary diameters and the strongest
angiographic signs of an impaired coronary blood flow.
Cardiac lactate metabolism presented with a cardiac lactate
production in these patients. Compared with subgroup III,
most of the patients in subgroup II (moderate CI) had larger
coronary diameters and more frequent “slow flow,” “stasis”
and “milking phenomenon.” These differences in terms of
the stigmata of an impaired blood flow were statistically
significant (p , 0.04).
DISCUSSION
Epidemiological aspects. The clinical significance of CEA
has been a controversial topic of discussion (2–8). So far,
symptomatology and angiographic features of this entity
have not been the object of a systematic investigation. The
coexistence with occlusive coronary artery disease has raised
the question of whether CEA is a variant of atherosclerotic
ischemic heart disease or a distinct entity.
The incidence of CEA in patients catheterized for
suspected coronary insufficiency has been reported to ac-
count for 0.3% to 4.9%, regardless of associated coronary
artery stenosis (21). These differences may reflect the
arbitrary use of the terms “ectasia” and “aneurysm.”
Only limited information is available on the clinical
implications of “dilated coronaropathy,” in which coronary
artery stenosis and anomalies, valvular and other cardiac
defects, are not present. Based on smaller studies by Swaye
et al. (7) and Hartnell et al. (4), an angiographic frequency
of 0.1% to 0.32% has been reported.
Etiology and angiographic appearance. In all patients
reported in the literature, true aneurysms have been discov-
ered. In most of the cases with isolated CEA (as well as in
our study), a bilateral fusiform manifestation was found. In
unilateral forms, the coronary luminal dilation is located in
40% to 85% in the RCA compared with 30% to 50% in the
LAD and LCX (4,8).
The etiology of CEA comprises various possibilities. The
majority of CEA are due to coronary artery atherosclerosis
(50%). A continuous spectrum of lesions from shallow and
angiographically insignificant atheromatous ulcerations in a
localized area to a diffuse ulcerative process with significant
stenosis has been described in association with CEA
(2,8,11,22). In most cases, pre- and poststenotic CEA
(3,6,7) were found; however, luminal dilations may affect
other vessel segments as well (23–25). In 20% to 30%, CEA
have been classified as congenital coronary anomalies either
as isolated lesions (1) or associated with other congenital
cardiac defects (12,20). In 10% to 20%, CEA are attributed
to inflammatory diseases such as Kawasaki disease (25),
Takayashu disease (26) or mycotic coronary lesions (27).
Another 10% to 20% of CEA are associated with collag-
enosis (sclerodermal heart disease [28], polyarteritis nodosa
[29], systemic lupus erythematosus [30]) or connective
tissue diseases (Ehlers-Danlos syndrome [31], Marfan syn-
drome [32]). The question of how congenital CEA could be
differentiated from acquired forms by clinical and angio-
graphic criteria has given rise to apparently conflicting
statements. The age of manifestation of clinical symptoms
cannot always be used as an indicator. However, congenital
CEA usually become clinically apparent in infancy and
childhood, whereas CEA related to inflammatory diseases
develop later in life but still earlier than those of atheroscle-
rotic nature (2). In most of the cases, the etiology remains
completely unknown, and most authors refrain from ascrib-
ing any cause to the luminal enlargement. In our patients,
the most likely etiology seems to be coronary atherosclerosis
because of the age of manifestation (53.2 6 7.3 years) and
because clinical examinations and laboratory investigations
revealed no evidence of a collagenosis, connective tissue or
inflammatory disease.
Extracardiac vessel dilations were reported only by Daoud
et al. (24) and Stajduhar et al. (34), who described an
overproportional coincidence of coronary artery aneurysms
with aneurysms of the aorta abdominalis.
Histopathological findings. The main histopathological
alteration of atherosclerotic CEA is an intimal proliferation
with spreading of plaque material into the vessel media. As
a pathomechanism for the development of pre- and post-
stenotic CEA, an increase in wall stress to which the artery
is exposed with the thinning and atherosclerotic destruction
of the vessel media resulting in progressive vessel dilation is
proposed (24,35).
However, coronary artery stenosis and atherosclerosis,
respectively, are not a conditio sine qua non for the
development of CEA. Rath et al. (11) and Mattern et al.
(36) described histologically evaluated nonatherosclerotic
forms of CEA with an intact vessel intima but with
extensive media degeneration and smooth muscle cell re-
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placement by hyalinized collagen, with subsequent marked
attenuation of the vessel wall. Thus, a functional loss of the
musculoelastic components of the coronary artery media is
considered to be the common pathway in the pathogenesis
of the disease (3,5,8).
Clinical symptoms and pathophysiological explanations.
Although patients with CEA complain mainly of typical
exertional angina pectoris, unstable angina has occasionally
been noted. These symptoms may also occur without
associated coronary artery stenosis. It has been hypothesized
that altered blood flow in CEA will predispose patients to
the development of myocardial infarction and increased
mortality. Coronary insufficiency and myocardial infarctions
are attributed to embolization of intracoronary parietal
thrombus to the distal coronary tree. In cases of Q wave
infarctions (the most common severe complication in iso-
lated CEA), thrombotic occlusions of the infarct vessel have
been angiographically documented in several studies
(4,6,8,22). An alternative explanation for myocardial infarc-
tions is that both occlusion and CEA are different manifes-
tations of one disease, namely atherosclerosis. Microembo-
lisms with consecutive disturbance of coronary perfusion
may account for ventricular arrhythmias and even sudden
cardiac death; the occlusion of major coronary vessels may
result in acute ventricular dysfunction (9,21). On the other
hand, a spontaneous rupture of an aneurysmatic coronary
artery is rare (7).
In previous studies, “sluggish circulation,” “swirling” and
“strikingly slow and scattered clearance of contrast material”
have been reported as typical angiographic patterns. The
relevance of these angiographic observations with regard to
clinical manifestations of myocardial ischemia, however, has
not yet been elucidated. In our study group, we detected a
significant stronger degree of these angiographic stigmata of
an impaired blood flow with increasing coronary luminal
enlargement. The pathophysiological explanation for this
phenomenon may be a conversion from a laminar to a
turbulent coronary flow in the dilated segments. Frequently,
streaming can be denoted by the admixture of blood with
dye, resulting in a poorly defined lumen due to “pseudo
filling defects.” (11,12,37). According to Hagen-Poiseuille’s
law, blood flow velocity decreases with an increasing vessel
diameter, but this physical law is valid only in the case of a
laminar flow of a homogeneous fluid. As a result of the
specific flow properties of blood (Reynold’s law), viscosity
increases below a critical blood flow velocity, with a loss of
an axial stream leading to erythrocyte aggregations (loss of
the Fahraeus-Lindqvist-effect) and an activation of platelets
and the coagulation system (36).
Rath et al. (11) and Tambe et al. (38) described an
extremely delayed coronary flow in patients with isolated
coronary aneurysm. The authors called this phenomenon
“slow-flow” and discussed a causal elevation of the coronary
resistance as well as a pathological reduction of the coronary
flow reserve.
In the present study, clinical symptoms were documented
as a typical exertional angina pectoris; in some patients, even
unstable angina occurred. We found an appreciable inci-
dence of non–Q wave and Q wave myocardial infarctions
accounting for 33% in our collective.
Evidence of exercise-induced myocardial ischemia. So
far, little data exist concerning a validated CI in isolated
CEA (4,5,8,11,24). This study presents the first investiga-
tion of a larger number of patients with “dilated coronar-
opathy” demonstrating evidence of a corresponding
exercise-induced CI in an ergometry and a coronary sinus
stress test. The severity of coronary insufficiency signifi-
cantly correlated with the size of the coronary luminal
enlargement in the proximal segment of the LAD (Fig. 3)
as well as the middle segments of the LAD and LCX,
respectively. In subgroup I, with bilateral large coronary
aneurysms, we found the strongest extent of angiographic
signs of an impaired coronary blood flow and the strongest
ischemic response with a frank lactate production and
significant ST segment depressions. Subgroup II presented
Figure 3. Influence of the extent of luminal enlargement on the
CLM in CEA. Depicted are the coronary artery diameters of every
patient’s proximal LAD segment on the abscissa and the maxi-
mum rate of CLM under atrial pacing on the ordinate. A
significant correlation was found (p , 0.001, r 5 0.87) between
the diameters of the subgroups I (solid triangle), II (open circles)
and III (3) and the severity of CI due to the CLM.
Table 2. Angiographic Patterns and Distribution of Stigmata of
an Impaired Coronary Blood Flow in the Subgroups I to III
Angiographic
Patterns/Stigmata
Subgroup
I
Subgroup
II
Subgroup
III
Bilateral aneurysms 16/18 2/14 0/10
Unilateral ectasia and unilateral
aneurysm
2/18 1/14 0/10
Bilateral ectasias 0/18 11/14 10/10
Delayed filling and drainage of
dye
17/18 11/14 7/14
Segmental back flow
phenomenon
16/18 9/14 3/10
Local deposition of dye 18/18 8/14 0/10
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with a moderate ischemia, compared with subgroup III,
with smaller bilateral coronary ectasias, in which CLM was
not significantly altered under pacing stress. Thus, the
differentiation between coronary artery ectasias and aneu-
rysms is of evident functional importance.
It is remarkable that NTG was of no therapeutic benefit
and did not improve the clinical symptoms and ischemic
response in our coronary sinus investigation. In subgroup I,
we could even see a paradoxical effect of NTG leading to a
significant aggravation of CI. This finding is in contrast to
the NTG effect in stenotic coronary artery disease, where
the drug had been proven to restore CI in coronary sinus
studies (39,40).
Therapeutic management. The coronary morphology of
CEA is heterogeneous; for this reason, pharmacological,
interventional and surgical therapy specific to the cause is
required. In addition to the determination of the cause,
therapeutic managament depends on possible or manifest
complications.
The application of platelet inhibitors as a prophylaxis
against ischemic syndromes attributed to fibrin thrombus
formation and microemboli showering is indispensable in all
forms of CEA (5,7,9). Heparin infusion is expected to
reduce intracoronary thrombus formation, which is espe-
cially regarded as a factor contributing to unstable angina.
Anticoagulation with cumarin has been propagated, al-
though a therapeutic superiority compared with aspirin has
not yet been evaluated (3,11). Fibrinolytic as well as inter-
ventional recanalization of the vessel constitutes therapy in
thrombotic occluded CEA (10).
In patients with associated significant coronary artery
stenosis, treatment should follow the guidelines for revas-
cularization (41).
The results of our study strongly suggest that NTG has
no therapeutic benefit in “dilated coronaropathy,” but it may
lower the ischemic threshold. Consequently, the adminis-
tration of nitrates in “dilated coronaropathy” should be
avoided.
In our study group, CI development depended on heart
rate; therefore, a reasonable therapeutic approach might be
the administration of beta-blockers due to their negative
chronotropic effect and reduction of myocardial oxygen
consumption in the absence of vasodilation (42).
Reprint requests and correspondence: Prof. Abdolhamid
Sheikhzadeh, University Hospital Lu¨beck, Ratzeburger Allee 160,
23538 Lu¨beck, Germany.
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